Clincosm LogoSign in Get a demo

mds

Showing 51 - 75 of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

Terminated
Has Results
  • Leukemia, Myeloid, Chronic
  • +8 more
  • Stem Cell Transplant
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 31, 2020

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
Has Results
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

MDS Trial in Bethesda, Brick, Canton (IBI188, Azacitidine)

Suspended
  • MDS
  • Bethesda, Maryland
  • +2 more
Dec 17, 2020

MDS Trial in Chicago (Lenalidomide and azacitidine combination)

Terminated
Has Results
  • MDS
  • Lenalidomide and azacitidine combination
  • Chicago, Illinois
    Rush University Medical Center
Nov 2, 2020

Serum Erythropoietin Level,Ferritin Level and Fibrinogen in

Unknown status
  • MDS
  • (no location specified)
Sep 28, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
  • +1 more
Sep 9, 2020

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome Trial in Georgia, United States (AC220)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +4 more
Apr 23, 2020

MDS, Immunodeficiency, GATA2 Trial run by the NCI (Cyclophosphamide (CTX, Cytoxan), Fludarabine(Fludara,Berlex Laboratories),

Completed
Has Results
  • MDS
  • +2 more
  • Cyclophosphamide (CTX, Cytoxan)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 4, 2020

Leukemia, AML, MDS Trial in Houston (Azacitidine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma Trial run by the NCI (EPOCH-F/R, FLAG, Transplant Preparative Regimen

Terminated
  • Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Myelodysplastic Syndrome, MDS Trial in Gainesville, Tampa (Prednisone, Lenalidomide)

Completed
Has Results
  • Myelodysplastic Syndrome
  • MDS
  • Gainesville, Florida
  • +1 more
Dec 10, 2019

AML, MDS Trial in Madison (FLT-PET scans)

Terminated
  • AML
  • MDS
  • FLT-PET scans
  • Madison, Wisconsin
    University of Wisconsin
Dec 12, 2019

MDS, Acute Myeloid Leukemia, AML Trial in Saint Louis (CX-01, Azacitidine, Bone marrow biopsy)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 4, 2019

Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

Completed
Has Results
  • Blood Cancer
  • +7 more
  • non-myeloablative hematopoietic cell transplantation
  • +8 more
  • Stanford, California
    Stanford University School of Medicine
Nov 17, 2019

MDS, AML, Solid Tumors Trial in United States (azacitidine)

Completed
Has Results
  • MDS
  • +5 more
  • Berkeley, California
  • +10 more
Nov 6, 2019

Leukemia, MDS, Myelofibrosis Trial in Pittsburgh (drug, radiation, other)

Completed
  • Leukemia
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 11, 2019

Ascorbic Acid Levels in MDS, AML, and CMML Patients

Completed
  • Myelodysplastic Syndromes
  • +5 more
  • Peripheral blood collection
  • Grand Rapids, Michigan
  • +1 more
Sep 30, 2019

MDS, Cardiovascular Diseases, Inflammation Trial in Toronto (Genetic Mutations, Inflammatory and lipid markers, Computed

Unknown status
  • MDS
  • +2 more
  • Genetic Mutations
  • +2 more
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Sep 30, 2019

Leukemia, Lymphoma, MDS Trial in Chicago (Conditioning Regimen & GVHD Prophylaxis)

Withdrawn
  • Leukemia
  • +2 more
  • Conditioning Regimen & GVHD Prophylaxis
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hospital of Chicago
Aug 28, 2019

Study on High-risk MDS Patients Based on RNA-seq Technology

Recruiting
  • MDS
  • MDS group
  • Hangzhou, Zhejiang, China
    ZJHTCM
Apr 18, 2019

AML, MDS, CMML Trial in United States (E6201)

Terminated
Has Results
  • AML
  • +2 more
  • Denver, Colorado
  • +3 more
Mar 7, 2019

MDS, Leukemias, Lymphomas Trial in Baltimore (Busulfan, Cyclophosphamide, Total body irradiation)

Completed
Has Results
  • MDS
  • +2 more
  • Baltimore, Maryland
  • +1 more
Mar 13, 2019

MDS Trial in Bobigny (Azacitidine, Azacitidine associated with Valproic acid, Azacitidine associated with Lenalidomide)

Unknown status
  • MDS
  • Bobigny, France
    Avicenne hospital
Feb 18, 2019